References

1. Bezjak A , Paulus R , Gaspar LE , et al. Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG oncology/RTOG 0813 trial. J Clin Oncol. 2019; 37 ( 15 ): 1316 - 1325. 10.1200/JCO.18.00622

2. Singh AK , Gomez-Suescun JA , Stephans KL , et al. One versus three fractions of stereotactic body radiation therapy for peripheral stage I to II non-small cell lung cancer: a randomized, multi-institution, phase 2 trial. Int J Radiat Oncol Biol Phys. 2019; 105 ( 4 ): 752 - 759. 10.1016/j.ijrobp.2019.08.019

3. Videtic GMM , Hu C , Singh AK , et al. A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer: NRG oncology RTOG 0915 (NCCTG N0927). Int J Radiat Oncol Biol Phys. 2015; 93 ( 4 ): 757 - 764. 10.1016/j.ijrobp.2015.07.2260

4. Deek MP , Van der Eecken K , Sutera P , et al. Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic prostate cancer: analysis of STOMP and ORIOLE trials. J Clin Oncol. 2022; 40 ( 29 ): 3377 - 3382. 10.1200/JCO.22.00644

5. Palma DA , Olson R , Harrow S , et al. Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial. J Clin Oncol. 2020; 38 ( 25 ): 2830 - 2838. 10.1200/JCO.20.00818

6. Tsai CJ , Yang JT , Shaverdian N , et al. Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study. Lancet. 2024; 403 ( 10422 ): 171 - 182. 10.1016/S0140-6736(23)01857-3

7. Yang JT , Wijetunga NA , Pentsova E , et al. Randomized phase II trial of proton craniospinal irradiation versus photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis. J Clin Oncol. 2022; 40 ( 33 ): 3858 - 3867. 10.1200/JCO.22.01148

8. Kishan AU , Ma TM , Lamb JM , et al. Magnetic resonance imaging-guided vs computed tomography-guided stereotactic body radiotherapy for prostate cancer: the MIRAGE randomized clinical trial. JAMA Oncol. 2023; 9 ( 3 ): 365 - 373. 10.1001/jamaoncol.2022.6558

9. Chuong MD , Lee P , Low DA , et al. Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: a multi-center, open-label phase 2 study. Radiother Oncol. 2024; 191: 110064. 10.1016/j.radonc.2023.110064

10. Castelli J , Thariat J , Benezery K , et al. Weekly adaptive radiotherapy vs standard intensity-modulated radiotherapy for improving salivary function in patients with head and neck cancer: a phase 3 randomized clinical trial. JAMA Oncol. 2023; 9 ( 8 ): 1056 - 1064. 10.1001/jamaoncol.2023.1352

11. Hofman MS , Lawrentschuk N , Francis RJ , et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (propsma): a prospective, randomised, multicentre study. Lancet. 2020; 395 ( 10231 ): 1208 - 1216. 10.1016/S0140-6736(20)30314-7

12. June CH , Sadelain M . Chimeric antigen receptor therapy. N Engl J Med. 2018; 379 ( 1 ): 64 - 73. 10.1056/NEJMra1706169

13. Lee NY , Sherman EJ , Schöder H , et al. Hypoxia-directed treatment of human papillomavirus-related oropharyngeal carcinoma. J Clin Oncol. 2024; 42 ( 8 ): 940 - 950. 10.1200/JCO.23.01308

14. Dembrower K , Crippa A , Colón E , et al. Artificial intelligence for breast cancer detection in screening mammography in sweden: a prospective, population-based, paired-reader, non-inferiority study. Lancet Digit Health. 2023; 5 ( 10 ): e703 - e711. 10.1016/S2589-7500(23)00153-X

15. Perlow HK , Nalin AP , Handley D , et al. A prospective registry study of ⁶⁸Ga-DOTATATE PET/CT incorporation into treatment planning of intracranial meningiomas. Int J Radiat Oncol Biol Phys. 2024; 118 ( 4 ): 979 - 985. 10.1016/j.ijrobp.2023.10.014

16. Perlow HK , Raleigh DR , Wang TJC , et al. Consensus radiation treatment planning guidelines using (68)Ga-DOTATATE PET/CT for resected meningiomas. Int J Radiat Oncol Biol Phys. 2025; 122 ( 1 ): 150 - 158. 10.1016/j.ijrobp.2024.12.003

17. Kalinsky K , Barlow WE , Gralow JR , et al. 21-gene assay to inform chemotherapy benefit in node-positive breast cancer. N Engl J Med. 2021; 385 ( 25 ): 2336 - 2347. 10.1056/NEJMoa2108873

18. Sparano JA , Gray RJ , Makower DF , et al. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med. 2018; 379 ( 2 ): 111 - 121. 10.1056/NEJMoa1804710

19. Lu S , Kato T , Dong X , et al. osimertinib after chemoradiotherapy in stage III EGFR -mutated NSCLC. N Engl J Med. 2024; 391 ( 7 ): 585 - 597. 10.1056/NEJMoa2402614

20. Howell MD , Corrado GS , DeSalvo KB . Three epochs of artificial intelligence in health care. JAMA. 2024; 331 ( 3 ): 242 - 244. 10.1001/jama.2023.25057

21. McKinney SM , Sieniek M , Godbole V , et al. International evaluation of an AI system for breast cancer screening. Nature. 2020; 577 ( 7788 ): 89 - 94. 10.1038/s41586-019-1799-6

22. Cao K , Xia Y , Yao J , et al. Large-scale pancreatic cancer detection via non-contrast CT and deep learning. Nat Med. 2023; 29 ( 12 ): 3033 - 3043. 10.1038/s41591-023-02640-w

23. Ardila D , Kiraly AP , Bharadwaj S , et al. End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nat Med. 2019; 25 ( 6 ): 954 - 961. 10.1038/s41591-019-0447-x

24. Liu Y , Jain A , Eng C , et al. A deep learning system for differential diagnosis of skin diseases. Nat Med. 2020; 26 ( 6 ): 900 - 908. 10.1038/s41591-020-0842-3

25. Ayers JW , Poliak A , Dredze M , et al. Comparing physician and artificial intelligence chatbot responses to patient questions posted to a public social media forum. JAMA Intern Med. 2023; 183 ( 6 ): 589 - 596. 10.1001/jamainternmed.2023.1838

26. Nayak A , Alkaitis MS , Nayak K , et al. Comparison of history of present illness summaries generated by a chatbot and senior internal medicine residents. JAMA Intern Med. 2023; 183 ( 9 ): 1026 - 1027. 10.1001/jamainternmed.2023.2561

27. Hong JC , Eclov NCW , Dalal NH , et al. System for high-intensity evaluation during radiation therapy (SHIELD-RT): a prospective randomized study of machine learning-directed clinical evaluations during radiation and chemoradiation. J Clin Oncol. 2020; 38 ( 31 ): 3652 - 3661. 10.1200/JCO.20.01688

28. Kann BH , Hicks DF , Payabvash S , et al. Multi-institutional validation of deep learning for pretreatment identification of extranodal extension in head and neck squamous cell carcinoma. J Clin Oncol. 2020; 38 ( 12 ): 1304 - 1311. 10.1200/JCO.19.02031

29. Kann BH , Likitlersuang J , Bontempi D , et al. Screening for extranodal extension in HPV-associated oropharyngeal carcinoma: evaluation of a CT-based deep learning algorithm in patient data from a multicentre, randomised de-escalation trial. Lancet Digit Health. 2023; 5 ( 6 ): e360 - e369. 10.1016/S2589-7500(23)00046-8

30. Huynh E , Hosny A , Guthier C , et al. Artificial intelligence in radiation oncology. Nat Rev Clin Oncol. 2020; 17 ( 12 ): 771 - 781. 10.1038/s41571-020-0417-8

31. Kalsi S , French H , Chhaya S , et al. The evolving role of artificial intelligence in radiotherapy treatment planning-a literature review. Clin Oncol (R Coll Radiol). 2024; 36 ( 10 ): 596 - 605. 10.1016/j.clon.2024.06.005

32. Kawamura M , Kamomae T , Yanagawa M , et al. Revolutionizing radiation therapy: the role of AI in clinical practice. J Radiat Res. 2024; 65 ( 1 ): 1 - 9. 10.1093/jrr/rrad090

33. Parkinson C , Matthams C , Foley K , Spezi E . Artificial intelligence in radiation oncology: a review of its current status and potential application for the radiotherapy workforce. Radiography (Lond). 2021; 27 Suppl 1: S63 - S68. 10.1016/j.radi.2021.07.012

34. Zeleznik R , Weiss J , Taron J , et al. Deep-learning system to improve the quality and efficiency of volumetric heart segmentation for breast cancer. NPJ Digit Med. 2021; 4 ( 1 ): 43. 10.1038/s41746-021-00416-5

35. Ma L , Yang Y , Ma J , et al. Correlation between AI-based CT organ features and normal lung dose in adjuvant radiotherapy following breast-conserving surgery: a multicenter prospective study. BMC Cancer. 23 ( 1 ): 1085. 10.1186/s12885-023-11554-2

36. Jayachandran Preetha C , Meredig H , Brugnara G , et al. Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study. Lancet Digit Health. 2021; 3 ( 12 ): e784 - e794. 10.1016/S2589-7500(21)00205-3

37. Tsang DS , Tsui G , Santiago AT , et al. A prospective study of machine learning-assisted radiation therapy planning for patients receiving 54 Gy to the brain. Int J Radiat Oncol Biol Phys. 2024; 119 ( 5 ): 1429 - 1436. 10.1016/j.ijrobp.2024.02.022

38. George E , Flagg E , Chang K , et al. Radiomics-based machine learning for outcome prediction in a multicenter phase II study of programmed death-ligand 1 inhibition immunotherapy for glioblastoma. AJNR Am J Neuroradiol. 2022; 43 ( 5 ): 675 - 681. 10.3174/ajnr.A7488

39. Friesner ID , Feng J , Kalnicki S , et al. Machine learning-based prediction of hospitalization during chemoradiotherapy with daily step counts. JAMA Oncol. 2024; 10 ( 5 ): 642 - 647. 10.1001/jamaoncol.2024.0014

40. Kehayias CE , Yan Y , Bontempi D , et al. Prospective deployment of an automated implementation solution for artificial intelligence translation to clinical radiation oncology. Front Oncol. 2023; 13: 1305511. 10.3389/fonc.2023.1305511

41. Natesan D , Eisenstein EL , Thomas SM , et al. Health care cost reductions with machine learning-directed evaluations during radiation therapy—an economic analysis of a randomized controlled study. NEJM AI. 2024; 1 ( 4 ): AIoa2300118. 10.1056/aioa2300118

42. Wang D , Lee SH , Geng H , et al. Interpretable machine learning for predicting pathologic complete response in patients treated with chemoradiation therapy for rectal adenocarcinoma. Front Artif Intell. 2022; 5: 1059033. 10.3389/frai.2022.1059033

43. Wesdorp NJ , Zeeuw JM , Postma SCJ , et al. Deep learning models for automatic tumor segmentation and total tumor volume assessment in patients with colorectal liver metastases. Eur Radiol Exp. 2023; 7 ( 1 ): 75. 10.1186/s41747-023-00383-4

44. Fremond S , Andani S , Barkey Wolf J , et al. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts. Lancet Digit Health. 2023; 5 ( 2 ): e71 - e82. 10.1016/S2589-7500(22)00210-2

45. Walker GV , Awan M , Tao R , et al. Prospective randomized double-blind study of atlas-based organ-at-risk autosegmentation-assisted radiation planning in head and neck cancer. Radiother Oncol. 2014; 112 ( 3 ): 321 - 325. 10.1016/j.radonc.2014.08.028

46. Men K , Geng H , Zhong H , et al. A deep learning model for predicting xerostomia due to radiation therapy for head and neck squamous cell carcinoma in the RTOG 0522 clinical trial. Int J Radiat Oncol Biol Phys. 2019; 105 ( 2 ): 440 - 447. 10.1016/j.ijrobp.2019.06.009

47. Sher DJ , Godley A , Park Y , et al. Prospective study of artificial intelligence-based decision support to improve head and neck radiotherapy plan quality. Clin Transl Radiat Oncol. 2021; 29: 65 - 70. 10.1016/j.ctro.2021.05.006

48. Osapoetra LO , Dasgupta A , DiCenzo D , et al. Assessment of clinical radiosensitivity in patients with head-neck squamous cell carcinoma from pre-treatment quantitative ultrasound radiomics. Sci Rep. 2021; 11 ( 1 ): 6117. 10.1038/s41598-021-85221-6

49. Mashayekhi M , McBeth R , Nguyen D , et al. Artificial intelligence guided physician directive improves head and neck planning quality and practice uniformity: a prospective study. Clin Transl Radiat Oncol. 2023; 40: 100616. 10.1016/j.ctro.2023.100616

50. Sher DJ , Moon DH , Vo D , et al. Efficacy and quality-of-life following involved nodal radiotherapy for head and neck squamous cell carcinoma: the INRT-AIR phase II clinical trial. Clin Cancer Res. 2023; 29 ( 17 ): 3284 - 3291. 10.1158/1078-0432.CCR-23-0334

51. Nicolae A , Semple M , Lu L , et al. Conventional vs machine learning-based treatment planning in prostate brachytherapy: results of a phase I randomized controlled trial. Brachytherapy. 2020; 19 ( 4 ): 470 - 476. 10.1016/j.brachy.2020.03.004

52. McIntosh C , Conroy L , Tjong MC , et al. Clinical integration of machine learning for curative-intent radiation treatment of patients with prostate cancer. Nat Med. 2021; 27 ( 6 ): 999 - 1005. 10.1038/s41591-021-01359-w

53. Sanders JW , Kudchadker RJ , Tang C , et al. Prospective evaluation of prostate and organs at risk segmentation software for MRI-based prostate radiation therapy. Radiol Artif Intell. 2022; 4 ( 2 ): e210151. 10.1148/ryai.210151

54. Thomas C , Dregely I , Oksuz I , et al. Neural network dose prediction for rectal spacer stratification in dose‐escalated prostate radiotherapy. Med Phys. 2022; 49 ( 4 ): 2172 - 2182. 10.1002/mp.15575

55. Johnsson K , Brynolfsson J , Sahlstedt H , et al. Analytical performance of apromise: automated anatomic contextualization, detection, and quantification of [(18)F]DCFPyL (PSMA) imaging for standardized reporting. Eur J Nucl Med Mol Imaging. 2022; 49 ( 3 ): 1041 - 1051. 10.1007/s00259-021-05497-8

56. Esteva A , Feng J , van der Wal D , et al. Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials. NPJ Digit Med. 2022; 5 ( 1 ): 71. 10.1038/s41746-022-00613-w

57. Spratt DE , Tang S , Sun Y , et al. Artificial intelligence predictive model for hormone therapy use in prostate cancer. NEJM Evid. 2023; 2 ( 8 ): EVIDoa2300023. 10.1056/EVIDoa2300023

58. Ross AE , Zhang J , Huang H-C , et al. External validation of a digital pathology-based multimodal artificial intelligence architecture in the NRG/RTOG 9902 phase 3 trial. Eur Urol Oncol. 2024; 7 ( 5 ): 1024 - 1033. 10.1016/j.euo.2024.01.004

59. Spratt DE , Liu VYT , Jia AY , et al. Meta-analysis of individual patient-level data for a multimodal artificial intelligence biomarker in high-risk prostate cancer: results from six NRG/RTOG phase 3 randomized trials. Eur Urol. 2024; 86 ( 4 ): 369 - 371. 10.1016/j.eururo.2024.06.019

60. Wong J , Fong A , McVicar N , et al. Comparing deep learning-based auto-segmentation of organs at risk and clinical target volumes to expert inter-observer variability in radiotherapy planning. Radiother Oncol. 2020; 144: 152 - 158. 10.1016/j.radonc.2019.10.019

61. Glaessgen A , Hamberg H , Pihl C-G , et al. Interobserver reproducibility of percent gleason grade 4/5 in total prostatectomy specimens. J Urol. 2002; 168 ( 5 ): 2006 - 2010. 10.1016/S0022-5347(05)64283-8

62. Sadimin ET , Khani F , Diolombi M , Meliti A , Epstein JI . Interobserver reproducibility of percent gleason pattern 4 in prostatic adenocarcinoma on prostate biopsies. Am J Surg Pathol. 2016; 40 ( 12 ): 1686 - 1692. 10.1097/PAS.0000000000000714

63. Zhu L , Pan J , Mou W , et al. Harnessing artificial intelligence for prostate cancer management. Cell Rep Med. 2024; 5 ( 4 ): 101506. 10.1016/j.xcrm.2024.101506

64. Network NCC. Prostate cancer (Version 1.2025). Accessed 22 January 2025. https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf

65. Bernier J , Domenge C , Ozsahin M , et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004; 350 ( 19 ): 1945 - 1952. 10.1056/NEJMoa032641

66. Cooper JS , Pajak TF , Forastiere AA , et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004; 350 ( 19 ): 1937 - 1944. 10.1056/NEJMoa032646

67. Chai RL , Rath TJ , Johnson JT , et al. Accuracy of computed tomography in the prediction of extracapsular spread of lymph node metastases in squamous cell carcinoma of the head and neck. JAMA Otolaryngol Head Neck Surg. 2013; 139 ( 11 ): 1187 - 1194. 10.1001/jamaoto.2013.4491

68. Maxwell JH , Rath TJ , Byrd JK , et al. Accuracy of computed tomography to predict extracapsular spread in p16-positive squamous cell carcinoma. Laryngoscope. 2015; 125 ( 7 ): 1613 - 1618. 10.1002/lary.25140

69. Url C , Schartinger VH , Riechelmann H , et al. Radiological detection of extracapsular spread in head and neck squamous cell carcinoma (HNSCC) cervical metastases. Eur J Radiol. 2013; 82 ( 10 ): 1783 - 1787. 10.1016/j.ejrad.2013.04.024

70. Nichols AC , Theurer J , Prisman E , et al. Randomized trial of radiotherapy versus transoral robotic surgery for oropharyngeal squamous cell carcinoma: long-term results of the ORATOR trial. J Clin Oncol. 2022; 40 ( 8 ): 866 - 875. 10.1200/JCO.21.01961

71. Ferris RL , Flamand Y , Weinstein GS , et al. Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN cancer research group trial (E3311). J Clin Oncol. 2022; 40 ( 2 ): 138 - 149. 10.1200/JCO.21.01752

72. Kann BH , Aneja S , Loganadane GV , et al. Pretreatment identification of head and neck cancer nodal metastasis and extranodal extension using deep learning neural networks. Sci Rep. 2018; 8 ( 1 ): 14036. 10.1038/s41598-018-32441-y

73. Maguire PD , Neal CR , Hardy SM , Schreiber AM . Single-arm phase 2 trial of elective nodal dose reduction for patients with locoregionally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2018; 100 ( 5 ): 1210 - 1216. 10.1016/j.ijrobp.2017.12.277

74. Sher DJ , Pham N-L , Shah JL , et al. Prospective phase 2 study of radiation therapy dose and volume de-escalation for elective neck treatment of oropharyngeal and laryngeal cancer. Int J Radiat Oncol Biol Phys. 2021; 109 ( 4 ): 932 - 940. 10.1016/j.ijrobp.2020.09.063

75. Tsai CJ , McBride SM , Riaz N , et al. Evaluation of substantial reduction in elective radiotherapy dose and field in patients with human papillomavirus-associated oropharyngeal carcinoma treated with definitive chemoradiotherapy. JAMA Oncol. 2022; 8 ( 3 ): 364 - 372. 10.1001/jamaoncol.2021.6416

76. Chen L , Dohopolski M , Zhou Z , et al. Attention guided lymph node malignancy prediction in head and neck cancer. Int J Radiat Oncol Biol Phys. 2021; 110 ( 4 ): 1171 - 1179. 10.1016/j.ijrobp.2021.02.004

77. Chen L , Zhou Z , Sher D , et al. Combining many-objective radiomics and 3D convolutional neural network through evidential reasoning to predict lymph node metastasis in head and neck cancer. Phys Med Biol. 64 ( 7 ): 075011. 10.1088/1361-6560/ab083a

78. Dohopolski M , Chen L , Sher D , Wang J . Predicting lymph node metastasis in patients with oropharyngeal cancer by using a convolutional neural network with associated epistemic and aleatoric uncertainty. Phys Med Biol. 2020; 65 ( 22 ): 225002. 10.1088/1361-6560/abb71c

79. Donzé JD , Williams MV , Robinson EJ , et al. International validity of the HOSPITAL score to predict 30-day potentially avoidable HOSPITAL readmissions. JAMA Intern Med. 2016; 176 ( 4 ): 496 - 502. 10.1001/jamainternmed.2015.8462

80. Frizzell JD , Liang L , Schulte PJ , et al. Prediction of 30-day all-cause readmissions in patients hospitalized for heart failure: comparison of machine learning and other statistical approaches. JAMA Cardiol. 2017; 2 ( 2 ): 204 - 209. 10.1001/jamacardio.2016.3956

81. Nguyen OK , Makam AN , Clark C , et al. Predicting all-cause readmissions using electronic health record data from the entire hospitalization: model development and comparison. J Hosp Med. 2016; 11 ( 7 ): 473 - 480. 10.1002/jhm.2568

82. Tevis SE , Weber SM , Kent KC , Kennedy GD . Nomogram to predict postoperative readmission in patients who undergo general surgery. JAMA Surg. 2015; 150 ( 6 ): 505 - 510. 10.1001/jamasurg.2014.4043

83. Hong JC , Niedzwiecki D , Palta M , Tenenbaum JD . Predicting emergency visits and hospital admissions during radiation and chemoradiation: an internally validated pretreatment machine learning algorithm. JCO Clin Cancer Inform. 2018; 2: 1 - 11. 10.1200/CCI.18.00037

84. Hong JC , Eclov NCW , Stephens SJ , Mowery YM , Palta M . Implementation of machine learning in the clinic: challenges and lessons in prospective deployment from the system for high intensity evaluation during radiation therapy (SHIELD-RT) randomized controlled study. BMC Bioinformatics. 2022; 23 ( suppl 12 ): 408. 10.1186/s12859-022-04940-3

85. Glide-Hurst CK , Lee P , Yock AD , et al. Adaptive radiation therapy (ART) strategies and technical considerations: a state of the ART review from NRG oncology. Int J Radiat Oncol Biol Phys. 2021; 109 ( 4 ): 1054 - 1075. 10.1016/j.ijrobp.2020.10.021

86. Jia X , Rong Y , Wu Q , et al. NRG oncology assessment of artificial intelligence for automatic treatment planning in radiation therapy clinical trials: present and future. Int J Radiat Oncol Biol Phys. 2025. 10.1016/j.ijrobp.2025.03.045

87. Rong Y , Chen Q , Fu Y , et al. NRG oncology assessment of artificial intelligence deep learning-based auto-segmentation for radiation therapy: current developments, clinical considerations, and future directions. Int J Radiat Oncol Biol Phys. 2024; 119 ( 1 ): 261 - 280. 10.1016/j.ijrobp.2023.10.033

88. Xiao Y , Benedict S , Cui Y , et al. Embracing the future of clinical trials in radiation therapy: an NRG oncology CIRO technology retreat whitepaper on pioneering technologies and AI-driven solutions. Int J Radiat Oncol Biol Phys. 2025; 122 ( 2 ): 443 - 457. 10.1016/j.ijrobp.2025.01.006

September 2025Vol 14 • Issue 3

A Head and Neck Contour Grading System Provides an Objective Assessment of Radiation Oncology Resident Contouring Skills

Artificial Intelligence-Assisted Peer Review in Radiation Oncology

Auto-Contouring in Residency: Cutting Corners or Creating Confidence?

Recent Trends of Artificial Intelligence in Radiation Oncology: A Narrative Review of Prospective Studies

Artificial Intelligence: Aiding Precision and Practice in Radiation Oncology